The Oncosearch | Oncotarget

RNA binding protein RBM14 promotes radio-resistance in glioblastoma by regulating DNA repair and cell differentiation Research Paper

Ming Yuan, Charles G. Eberhart, Mihoko Kai

Published Apr 27, 2014 · Vol. 5, No. 9 · pp. 2820-2826

MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathways Priority Research Paper

Anne Y. Saiki, Sean Caenepeel, Dongyin Yu, Julie A. Lofgren, Tao Osgood, Rebecca Robertson, Jude Canon, Cheng Su, Adrie Jones, Xiaoning Zhao, Chetan Deshpande, Marc Payton, Jebediah Ledell, Paul E. Hughes, Jonathan D. Oliner

Published Apr 23, 2014 · Vol. 5, No. 8 · pp. 2030-2043

Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin Research Paper

Saman Maleki Vareki, Mateusz Rytelewski, Rene Figueredo, Di Chen, Peter J. Ferguson, Mark Vincent, Weiping Min, Xiufen Zheng, James Koropatnick

Published Apr 18, 2014 · Vol. 5, No. 9 · pp. 2778-2791

Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer Research Paper

Siti Norasikin Mohd Nafi, Daniele Generali, Gabriela Kramer-Marek, Merel Gijsen, Carla Strina, Mariarosa Cappelletti, Daniele Andreis, Syed Haider, Ji-Liang Li, Esther Bridges, Jacek Capala, Roxanis Ioannis, Adrian L. Harris, Anthony Kong

Published Apr 17, 2014 · Vol. 5, No. 15 · pp. 5934-5949

miR-17 inhibition enhances the formation of kidney cancer spheres with stem cell/ tumor initiating cell properties Research Paper

Zsuzsanna Lichner, Carol Saleh, Venkateswaran Subramaniam, Annetta Seivwright, Gerald Joseph Prudâ€™homme, George Makram Yousef

Published Apr 16, 2014 · Vol. 6, No. 8 · pp. 5567-5581

Pathways and therapeutic targets in melanoma Review

Emma Shtivelman, Michael A. Davies, Patrick Hwu, James Yang, Michal Lotem, Moshe Oren, Keith T. Flaherty, David E. Fisher

Published Apr 8, 2014 · Vol. 5, No. 7 · pp. 1701-1752

Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis Research Paper

Isabel Heidegger, Johann Kern, Philipp Ofer, Helmut Klocker, Petra Massoner

Published Apr 2, 2014 · Vol. 5, No. 9 · pp. 2723-2735

A new mosaic pattern in glioma vascularization: exogenous endothelial progenitor cells integrating into the vessels containing tumor-derived endothelial cells Research Paper

Xiao Chen, Jingqin Fang, Shunan Wang, Heng Liu, Xuesong Du, Jinhua Chen, Xue Li, Yizeng Yang, Bo Zhang, Weiguo Zhang

Published Apr 2, 2014 · Vol. 5, No. 7 · pp. 1955-1968

PDGFRÎ± up-regulation mediated by Sonic Hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation Research Paper

Francesco Sabbatino, Yangyang Wang, Xinhui Wang, Keith T. Flaherty, Ling Yu, David Pepin, Giosueâ€™ Scognamiglio, Stefano Pepe, John M. Kirkwood, Zachary A. Cooper, Dennie T. Frederick, Jennifer A. Wargo, Soldano Ferrone, Cristina R. Ferrone

Published Mar 31, 2014 · Vol. 5, No. 7 · pp. 1926-1941

Epigenetic plasticity: A central regulator of epithelial-to-mesenchymal transition in cancer Review

Upasana Bedi, Vivek Kumar Mishra, David Wasilewski, Christina Scheel, Steven A. Johnsen

Published Mar 28, 2014 · Vol. 5, No. 8 · pp. 2016-2029

FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor Research Paper

Koichi Azuma, Akihiko Kawahara, Kahori Sonoda, Kazutaka Nakashima, Kousuke Tashiro, Kosuke Watari, Hiroto Izumi, Masayoshi Kage, Michihiko Kuwano, Mayumi Ono, Tomoaki Hoshino

Published Mar 26, 2014 · Vol. 5, No. 15 · pp. 5908-5919

Pharmacologic down-regulation of EZH2 suppresses bladder cancer in vitro and in vivo Research Paper

Shou-Hung Tang, Hsu-Shan Huang, Hong-Ui Wu, Yi-Ta Tsai, Mei-Jen Chuang, Cheng-Ping Yu, Shih-Ming Huang, Guang-Huan Sun, Sun-Yran Chang, Pei-Wen Hsiao, Dah-Shyong Yu, Tai-Lung Cha

Published Mar 26, 2014 · Vol. 5, No. 21 · pp. 10342-10355

Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis Research Paper

Xenofon Papanikolaou, Sarah Johnson, Tarun Garg, Erming Tian, Ruslana Tytarenko, Qing Zhang, Caleb Stein, Bart Barlogie, Joshua Epstein, Christoph Heuck

Published Mar 24, 2014 · Vol. 5, No. 12 · pp. 4118-4128

Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinoma Research Paper

Hidetoshi Hayashi, Tokuzo Arao, Kazuko Matsumoto, Hideharu Kimura Kimura, Yosuke Togashi, Yoshinori Hirashima, Yosuke Horita, Satoru Iwasa, Natsuko Tsuda Okita, Yoshitaka Honma, Atsuo Takashima, Ken Kato, Tetsuya Hamaguchi, Yasuhiro Shimada, Kazuhiko Nakagawa, Kazuto Nishio, Yasuhide Yamada

Published Mar 22, 2014 · Vol. 5, No. 9 · pp. 2588-2595

Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus Research Paper

Sarina A. Piha-Paul, Jennifer J. Wheler, Siqing Fu, Charles Levenback, Karen Lu, Gerald S. Falchook, Aung Naing, David S. Hong, Apostolia M. Tsimberidou, Razelle Kurzrock

Published Mar 20, 2014 · Vol. 5, No. 7 · pp. 1846-1855

SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker. Priority Research Paper

Vamsi K. Kolukula, Geetaram Sahu, Anton Wellstein, Olga C. Rodriguez, Anju Preet, Vito Iacobazzi, Gabriella D'Orazi, Chris Albanese, Ferdinando Palmieri, Maria Laura Avantaggiati

Published Mar 16, 2014 · Vol. 5, No. 5 · pp. 1212-1225

Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity Research Paper

Kelly K. Haagenson, Jessica Wei Zhang, Zhengfan Xu, Malathy P.V. Shekhar, Gen Sheng Wu

Published Mar 13, 2014 · Vol. 5, No. 4 · pp. 1101-1115

Linking differential radiation responses to glioma heterogeneity Research Paper

Chao Ke, Katherine Tran, Yumay Chen, Anne T. Di Donato, Liping Yu, Yuanjie Hu, Mark E. Linskey, Ping H. Wang, Charles L. Limoli, Yi-Hong Zhou

Published Mar 12, 2014 · Vol. 5, No. 6 · pp. 1657-1665

Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy Research Paper

Bo Cao, Yanfeng Qi, Guanyi Zhang, Duo Xu, Yang Zhan, Xavier Alvarez, Zhiyong Guo, Xueqi Fu, Stephen R. Plymate, Oliver Sartor, Haitao Zhang, Yan Dong

Published Mar 4, 2014 · Vol. 5, No. 6 · pp. 1646-1656

Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia Priority Research Paper

Sabine Cerny-Reiterer, Renata A. Meyer, Harald Herrmann, Barbara Peter, Karoline V. Gleixner, Gabriele Stefanzl, Emir Hadzijusufovic, Winfried F. Pickl, Wolfgang R. Sperr, Junia V. Melo, Hiroshi Maeda, Ulrich JÃ¤ger, Peter Valent

Published Mar 4, 2014 · Vol. 5, No. 5 · pp. 1198-1211

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

RNA binding protein RBM14 promotes radio-resistance in glioblastoma by regulating DNA repair and cell differentiation Research Paper

MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathways Priority Research Paper

Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin Research Paper

Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer Research Paper

miR-17 inhibition enhances the formation of kidney cancer spheres with stem cell/ tumor initiating cell properties Research Paper

Pathways and therapeutic targets in melanoma Review

Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis Research Paper

A new mosaic pattern in glioma vascularization: exogenous endothelial progenitor cells integrating into the vessels containing tumor-derived endothelial cells Research Paper

PDGFRÎ± up-regulation mediated by Sonic Hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation Research Paper

Epigenetic plasticity: A central regulator of epithelial-to-mesenchymal transition in cancer Review

FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor Research Paper

Pharmacologic down-regulation of EZH2 suppresses bladder cancer in vitro and in vivo Research Paper

Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis Research Paper

Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinoma Research Paper

Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus Research Paper

SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker. Priority Research Paper

Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity Research Paper

Linking differential radiation responses to glioma heterogeneity Research Paper

Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy Research Paper

Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia Priority Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

RNA binding protein RBM14 promotes radio-resistance in glioblastoma by regulating DNA repair and cell differentiation Research Paper

MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathways Priority Research Paper

Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin Research Paper

Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer Research Paper

miR-17 inhibition enhances the formation of kidney cancer spheres with stem cell/ tumor initiating cell properties Research Paper

Pathways and therapeutic targets in melanoma Review

Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis Research Paper

A new mosaic pattern in glioma vascularization: exogenous endothelial progenitor cells integrating into the vessels containing tumor-derived endothelial cells Research Paper

PDGFRÎ± up-regulation mediated by Sonic Hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation Research Paper

Epigenetic plasticity: A central regulator of epithelial-to-mesenchymal transition in cancer Review

FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor Research Paper

Pharmacologic down-regulation of EZH2 suppresses bladder cancer in vitro and in vivo Research Paper

Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis Research Paper

Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinoma Research Paper

Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus Research Paper

SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker. Priority Research Paper

Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity Research Paper

Linking differential radiation responses to glioma heterogeneity Research Paper

Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy Research Paper

Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia Priority Research Paper